COVID‐19 in patients with myasthenia gravis

Introduction Coronavirus disease 2019 (COVID‐19) has rapidly become a global pandemic, but little is known about its potential impact on patients with myasthenia gravis (MG). Methods We studied the clinical course of COVID‐19 in five hospitalized patients with autoimmune MG (four with acetylcholine...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Muscle & nerve 2020-08, Vol.62 (2), p.254-258
Hauptverfasser:	Anand, Pria, Slama, Michaël C. C., Kaku, Michelle, Ong, Charlene, Cervantes‐Arslanian, Anna M., Zhou, Lan, David, William S., Guidon, Amanda C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Clinical Research Short Report Clinical Research Short Reports Complications Coronaviruses COVID-19 immunosuppression Intravenous administration Intubation Kinases Muscles Myasthenia Myasthenia gravis neuroimmunology neuromuscular disorders Neuromuscular junctions Pandemics Patients Protein-tyrosine kinase Respiratory failure Thromboembolism Tyrosine Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!